A Study of BMS-986504 in People With Solid Tumor Cancer

Full Title

A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination with Other Agents in Participants with Advanced and/or Metastatic Solid Tumors with Homozygous MTAP Deletion (MountainTap-5)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Mrinal Gounder’s office at 646-608-2091.

Protocol
26-334
Phase
Phase II (phase 2)
Investigator
Mrinal M. Gounder
Co-Investigators
Kathryn C. Arbour
Diseases
Brain Tumors, Primary
Genitourinary Cancer › Bladder Cancer
Hepatobiliary › Pancreatic Cancer
Melanoma
Solid Tumors
Upper Gastrointestinal › Gastric Cancer
Upper Gastrointestinal › Pancreatic Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07492680
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description